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DNA-repair mechanisms enable cells to maintain their genetic
information by protecting it from mutations that may cause
malignant growth. Recent evidence suggests that speciﬁc DNA-
repair enzymes contain ISCs (iron–sulfur clusters). The nuclear-
encoded protein frataxin is essential for the mitochondrial bio-
synthesisofISCs.Frataxindeﬁciencycausesaneurodegenerative
disorder named Friedreich’s ataxia in humans. Various types of
cancer occurring at young age are associated with this disease,
and hence with frataxin deﬁciency. Mice carrying a hepatocyte-
speciﬁc disruption of the frataxin gene develop multiple liver
tumoursforunresolvedreasons.Inthepresentstudy,weshowthat
frataxin deﬁciency in murine liver is associated with increased
basal levels of oxidative DNA base damage. Accordingly,
eukaryotic V79 ﬁbroblasts overexpressing human frataxin show
decreased basal levels of these modiﬁcations, while prokaryotic
Salmonella enterica serotype Typhimurium TA104 strains
transformed with human frataxin show decreased mutation rates.
TherepairratesofoxidativeDNAbasemodiﬁcationsinV79cells
overexpressing frataxin were signiﬁcantly higher than in control
cells. Lastly, cleavage activity related to the ISC-independent
repair enzyme 8-oxoguanine glycosylase was found to be
unaltered by frataxin overexpression. These ﬁndings indicate that
frataxin modulates DNA-repair mechanisms probably due to its
impact on ISC-dependent repair proteins, linking mitochondrial
dysfunction to DNA repair and tumour initiation.
Key words: DNA base excision repair, frataxin, Friedreich’s
ataxia, iron–sulfur cluster, oxidative stress, tumorigenesis.
INTRODUCTION
ISCs (iron–sulfur clusters) are small inorganic molecules that
can be found in all kingdoms of life. Being integrated into a
number of proteins, ISCs are involved in pivotal biochemical
functions including the citric acid cycle, amino acid synthesis,
respiration, nucleotide metabolism and iron-uptake regulation.
In the last 10 years, signiﬁcant knowledge about ISC biogenesis
and the assembly of ISC proteins has been gained [1,2]. In
eukaryotes, mitochondria harbour the ISC-assembly machinery.
Although these pathways are still awaiting further elucidation,
it appears generally accepted that the FRDA (Friedreich’s
ataxia)-associated protein frataxin is crucial for ISC biosynthesis
[3] and plays a primary role in ISC protein maturation in
human cells [4,5]. It should be noted, however, that additional
functionsforthefrataxinproteinhavebeenshownexperimentally
[6,7].
Defects in the frataxin gene and thereby a reduced level of
functional frataxin protein leads to a human disease named
FRDA (OMIM 229300), with serious clinical features including
abnormalities in glucose metabolism, limb and gait ataxia,
hypertrophic cardiomyopathy and reduced expectancy of life.
Although unconditional deletion of frataxin in mice causes early
embryonic lethality [9], Cre/loxP conditional knockout mice
[10–12] and GAA repeat knockin mice [13] unambiguously
reﬂect important physiological and biochemical features of the
human disease.
We have previously generated and characterized mice
with a Cre/loxP-mediated hepatocyte-speciﬁc disruption of
frataxin named AlbFxn
−/− [12]. These mice exhibit impaired
mitochondrial energy metabolism, increased oxidative stress and
severely reduced lifespan [12]. Unexpectedly, we also observed
liver tumour formation in almost all animals within the ﬁrst
12 months of life, whereas control animals rarely exhibit such
tumours during this time period. This ﬁnding is consistent with
several reports of malignant disorders in FRDA patients [14–17].
Moreover, we have described reduced malignancy in cancer
cells which stably overexpress frataxin [18,19] in a potentially
p38MAPK(mitogen-activatedproteinkinase)-dependentmanner
[19]. Consistently, in AlbFxn
−/− mice, we have shown impaired
activation of the p38 MAPK pathway, as well as changes in the
rates of proliferation suggesting a tumour-promoting effect of
frataxin deﬁciencyasonerelevantcauseforthetumour formation
[11]. However, potential changes in tumour-initiation processes
were not studied at that time.
Since then, dependency of DNA-repair enzymes on ISCs
[20,21] has been proposed and studied in more detail: the ISC-
containing DNA glycosylase MUTYH [human mutY homologue
(Escherichia coli)] has been shown to be involved in BER
(base excision repair), and alterations in the human MUTYH
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gene are associated with cancer [22]. Boal et al. [23] have
demonstrated a functional role of the ISC in mutY and two other
BER enzymes, namely Nth and AfUDG (Archeoglobus fulgidus
uracil DNA glycosylase). Furthermore, the DNA-repair helicases
XPD (xeroderma pigmentosum complementation group D) and
FancJ (Fanconi’s anaemia complementation group J), which are
involved in NER (nucleotide excision repair) and which are asso-
ciated with the human diseases xeroderma pigmentosum and
Fanconi’s anaemia, frequently resulting in skin cancer, leukaemia
and solid tumours, have been shown to contain ISCs that appear
to be essential for their respective helicase activities [24].
This recently established and presumably essential role of ISCs
in previously deﬁned processes of DNA repair, together with the
known relevance of DNA-repair enzymes on tumour initiation,
suggests that ISCs may be relevant for tumour suppression. In
the present study, we have tested this hypothesis by analysing
a murine model of targeted disruption of the ISC synthesis-
modulating frataxin gene in mammalian liver, as well as two
model systems overexpressing frataxin, with respect to DNA
repair and tumour initiation.
MATERIALS AND METHODS
Chemicals
Benzo[a]pyrene 4,5-oxide was kindly provided by Dr
Albrecht Seidel (Biochemisches Institut f¨ ur Umweltcarcinogene,
Grosshansdorf, Germany). All other chemicals were purchased
from Sigma–Aldrich.
Animal experimentation
Mice were kept in accordance with the Federation of European
Laboratory Animal Science Associations regulations and all
experiments were approved by the corresponding institutional
review board.
Mutagenicity in Salmonella enterica serotype Typhimurium
Salmonella Typhimurium strains TA104 and TA1538 were
kindly provided by Dr Bruce N. Ames (University of
California, Berkeley, CA, U.S.A.). Human frataxin cDNA
was recovered by ampliﬁcation from previously described
plasmids harbouring haemagglutinin-tagged frataxin [19] with
primers including suitable restriction sites for the target vectors,
AmesBac_FX_FWD (5
 -CGCGGATCCCCATGGGAACTTTG
GGCCACCCAGGCTCT-3
 ) and AmesBac_FX_REV (5
 -TG-
GGAATTCAAGCTTCTAGATGTATCGGTACGTGTCTGC-3
 )
(Invitrogen). Primers were designed to generate a coding
sequence beginning at amino acid 88, thereby leading to a
cDNA lacking the N-terminal mitochondrial localization signal
peptide [25]. The PCR product was cloned into pCR2.1
(Invitrogen) and conﬁrmed by sequencing. The frataxin cDNA
was then subcloned into the ampicillin-resistant target vector
pKK223-3 by digestion with NcoI and HindIII. Orientation
was tested by digestion with BamH1/HindIII and BamH1/Sac1.
The pKK223-3 plasmid containing the coding sequences for
frataxin was digested with HindIII and SalI restriction enzymes
and then cloned into the neomycin-resistant plasmid pKKneo
[26]. The bacteria containing either pCR2.1 or pKK223-3 were
grown on LB (Luria–Bertani) medium with ampicillin (100 μg/
ml). For selection of pKKneo, LB medium was supplemented
with neomycin (50 μg/ml). The pKKneo vector containing
frataxin cDNA and the control vector pKKneo [26] were
adapted to the restriction enzymes of Salmonella Typhimurium
LT2 by passaging them through the restriction-deﬁcient, but
methylation-proﬁcient, Salmonella Typhimurium strain LB5000.
Plasmids were recovered and used for the transformation of
the strains Salmonella Typhimurium TA104 and TA1538 with
frataxin and control vectors. The names of the resulting bacterial
strains consisted of the short name of the recipient cells (TA104
and TA1538) and the expressed protein, namely TA104-hFX,
TA104-Neo, TA1538-hFX and TA1538-Neo.
Theso-calledAmestestwasperformedasdescribedpreviously
[27]. Brieﬂy, nutrient broth (25 g/l Oxoid nutrient broth No. 2)
wasinoculatedwithbacteriaandgrownovernightat37◦C.Before
the experiment, bacteria were centrifuged at 9000 g for 10 min,
resuspended in medium B (1.6 g/l Bacto nutrient broth and 5 g/l
NaCl) andadjustednephelometrically toatitre of(1.1–1.8)×10
9
bacteria (colony-forming units)/ml. The bacterial suspension
(100 μl) and benzo[a]pyrene 4,5-oxide (in 10 μl DMSO) were
added sequentially to a glass tube containing 500 μl of 150 mM
K C la t3 7◦C. After 60 min, 2 ml of 45◦C warm top agar (0.55%
agar, 0.55% NaCl, 50 μM histidine, 50 μM tryptophan, 50 μM
biotin and 25 mM sodium phosphate buffer, pH 7.4) was added,
and the mixture was poured into a Petri dish containing 22 ml of
minimal agar (1.5% agar in Vogel-Bonner E medium with 2%
glucose). After incubation at 37◦C for 3 days in the dark, the
colonies (his
+ revertants) were counted. Initially, a dose-ﬁnding
experiment was carried out. The compounds were then tested
using three plates for each condition. In virtually all cases, the
individual values deviated from the mean by less than 10% or by
less than ten colonies.
Origin, culture and stable transfection of V79 Chinese hamster cells
V79 Chinese hamster cells were purchased from Deutsche
Sammlung von Mikroorganismen und Zellkulturen (DSMZ)
(German Collection of Microorganisms and Cell Lines,
Braunschweig, Germany). Cells were thawed and propagated in
DMEM(Dulbecco’smodiﬁedEagle’smedium)containing4.5 g/l
D-glucose and 10% fetal bovine serum, and three passages later
frozen in aliquots of 1 ml.
Transfection experiments were performed as described
previously using pCINeo (Promega) (control) and pCINeo-hFX
[19]; the latter containing a full-length frataxin, i.e. including the
N-terminal mitochondrial localization signal and a C-terminal
haemagglutinin tag. V79 cells were selected and maintained in
DMEM containing 4.5 g/l D-glucose, 10% fetal bovine serum
and 700 mg/l neomycin. Transfected cells were propagated as
described above, and three passages later frozen in aliquots
of 1 ml. The names of the resulting cell lines are V79-Neo
and V79-hFX. Detection of human frataxin was performed on
protein extracts containing 30 μg of protein by PAGE and
Western blotting using an anti-haemagglutinin antibody (Roche
Diagnostics) followed by a horseradish-peroxidase-labelled
secondary antibody and standard chemoluminescence detection.
To determine the growth curve, we seeded 2.5 × 10
4 cells into
72 replica 6-cm-diameter plastic dishes. The cells in eight dishes
were counted every 12 h, and growth curves were created. The
population doubling time was determined from the growth curve.
Oxygen consumption was measured using a Clark-type electrode
(Hansatech) as described previously [28]. For each measurement
2 × 10
6 cells suspended in HBSS (Hanks balanced salt solution)
were used.
HPRT (hypoxanthine phosphoribosyltransferase) gene mutation
test in Chinese hamster V79 cells
Six independent lines of frataxin-overexpressing and mock-
transfectedV79cellsweretreatedthreetimeswith10 mMKBrO3
for 1 h in 100-mm-diameter Petri dishes before subcultivation.
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Treatedculturesaswellascontrolcellsweretransferredasneeded
(minimum 2 × 10
6 cells). Following the third treatment, 10
6 cells
from each culture were plated into ﬁve new 100-mm-diameter
dishes with selective medium containing 7 μg/μl 6-thioguanine
to determine the number of mutants. The plating efﬁciency was
determined in non-selective medium plating 200 cells in 60-mm-
diameterdishes.After1 week,colonieswereﬁxedwithmethanol,
stained with sulforhodamine-B and counted.
Isolation of hepatocytes
AlbFxn
−/− mice were generated, bred and veriﬁed as described
previously [12]. For determination of oxidative DNA modiﬁ-
cations, hepatocytes from 3-week-old AlbFxn
−/− mice and
control genotypes (littermates) were isolated by a modiﬁed two-
step collagenase perfusion technique [29]. Brieﬂy, the liver
was perfused in situ via the portal vein for 15 min with an
EGTA-containing buffer at 37◦C. The perfusion was continued
for another 30 min with a collagenase-containing buffer. The
liver was removed; hepatocytes were carefully dissociated in
a suspension buffer and ﬁltered through a 100-μm gauze.
Hepatocytes were centrifuged at 15 g for 10 min and washed
twice in suspension buffer, before viability was determined by
Trypan Blue exclusion.
DNA-damage induction by photosensitization
In order to induce DNA damage, exponentially growing V79-
hFX cells and controls were irradiated with visible light in a
phosphate buffer containing 50 nM of the photosensitizer Ro 19-
8022 (Hoffmann La Roche). Cells were irradiated for 10 min on
ice from a distance of 0.38 m with a 1000 W halogen lamp. This
treatment oxidizes bases in DNA, but causes few direct strand
breaks [30]. Subsequently, cells were either analysed directly or
maintained under standard culture conditions for 4 h.
Quantiﬁcation of DNA modiﬁcations
An alkaline elution assay [31] in combination with 1 μg/ml
Fpg (formamido-pyrimidine DNA glycosylase), the bacterial
functional analogue of OGG1 (8-oxoguanine DNA glycosylase
1), was used to quantify various types of DNA modiﬁcation in
V79 cells [30] and in hepatocytes [32]. In this manner, SSBs
(DNA single-strand breaks) were determined by incubation of
the cellular DNA without Fpg immediately after cell lysis. The
number of modiﬁcations sensitive to Fpg was determined using
parallel ﬁlters with the repair enzyme. To quantify the Fpg-
sensitive modiﬁcations, the number of SSBs was subtracted,
whereas the background levels observed with untreated controls
were subtracted in all cases. γ-Irradiated cells were used for
calibration, assuming that 6 Gy induces 1 SSB/10
6 bp [31].
Cleavage activity of OGG1 in cell extracts
Approx.1.2×10
7 V79Chinesehamsterﬁbroblastsorhepatocytes
were washed with phosphate buffer, and the cell pellet was
resuspended in 200 μl of lysis buffer (200 mM Tris/HCl, pH 8,
10 mM EDTA and 2.5 M NaCl) containing protease inhibitors
(Complete
TM Mini from Roche Applied Science). After cells
were sonicated carefully, the suspension was centrifuged in a
60Ti rotor at 45000 rev./min for 45 min at 4◦C. The resulting
supernatant was used to determine the protein concentration
according to the method of Bradford. Cleavage activities at 8-
oxoG(7,8-dihydro-8-oxoguanine)sitesinthesecellextractswere
measured by incubating 5 μg of protein in a total volume of 32
μl for 1 h at 37◦C with a 34-mer 5
  32P-labelled double-stranded
oligodeoxyribonucleotide containing an 8-oxoG residue in the la-
Figure 1 Liver tumour formation and basal levels of oxidative DNA
modiﬁcations in frataxin-deﬁcient AlbFxn−/− mice
(A) Hepatocyte-speciﬁc disruption of frataxin expression in the liver and loading controls
are displayed by immunoblotting against murine frataxin protein (mFxb) and α-tubulin (Tub)
respectively. (B) Typical liver specimen of control and AlbFxn−/− mice. (C) Numbers of DNA
SSBs and Fpg-sensitive modiﬁcations (Fpg) in untreated hepatocytes as quantiﬁed using the
alkaline elution technique. Results are means+S.D. for 11 mice in each group. Signiﬁcant
difference between the groups is indicated according to a paired Student’s t test.
belled strand at position 16 opposite a cytosine. After performing
denaturing PAGE, the extent of DNA cleavage was quantiﬁed
using a Storm Phosphorimager (Molecular Dynamics) [33].
Statistical analyses
A Kolmogorov–Smirnov test was used for normality tests. We
found normality in all experiments. Unless noted otherwise, an
unpaired Student’s t test was used. P< 0.05 was considered to
be statistically signiﬁcant.
RESULTS
Tumorigenicity in frataxin-deﬁcient AlbFxn−/− mice is correlated
with oxidative DNA base modiﬁcations
In the present study, we used the Cre/loxP system to remove
exon 4 of the frataxin gene in a hepatocyte-speciﬁc manner. The
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Figure 2 Human frataxin protein protects from speciﬁc mutations in Salmonella Typhimurium
(A) Immunoblot analysis of recombinant frataxin expression in cytosolic preparations (20 μg of protein/lane) of Salmonella Typhimurium strains TA104-hFX and TA1538-hFX against murine
monoclonal HA clone 12CA5 (Roche) (18kDa). Neo, mock-transfected control strains. (B) Number of spontaneous revertant colonies per plate. Results are means+S.D. for three (TA104) and four
(TA1538) independent experiments. (C) Revertants per plate in the presence of various concentrations of benzo[a]pyrene 4,5-oxide. ,N e o ;, hFX.
absence of detectable frataxin protein following disruption was
shown by immunoblotting (Figure 1A). As published previously,
hepatocyte-speciﬁcfrataxin-knockoutmicedeveloplivertumours
early in life (Figure 1B) [12].
The previously described increase in oxidative stress in liver
specimensofAlbFxn
−/− mice[12]ledtotheassumptionthatthere
may be an increased oxidative DNA damage in such liver cells.
We tested this possibility in isolated hepatocytes from 3-week-
old AlbFxn
−/− mice and quantiﬁed basal levels of oxidative DNA
modiﬁcations in terms of SSBs and Fpg-sensitive modiﬁcations.
The latter include oxidative purine modiﬁcations such as 8-oxoG
andsitesofbaseloss[34].AsdepictedinFigure1(C),weobserved
that the deﬁciency of frataxin was associated with signiﬁcantly
increased levels of Fpg-sensitive lesions, but not of SSBs. This
selectivity is an indication that the effect is more likely to be
caused by a retardation of speciﬁc repair mechanisms rather than
by an increased generation of the damage. To test this hypothesis
and elucidate further the underlying mechanisms, we decided to
overexpress human frataxin in both prokaryotic and eukaryotic
model systems.
Overexpression of the human frataxin protein reduces DNA base
substitution-mediated mutations in prokaryotes
Impaired frataxin expression in humans reduces the activity
of ISC-dependent enzymes [35], whereas overexpression of
frataxin has been shown to increase the activity of ISC-
containing enzymes [28]. Given the above-mentioned ﬁndings
in frataxin-deﬁcient mice, we assumed that overexpression of
frataxin would conversely increase the ISC-mediated DNA-
repair capacity and therefore ultimately reduce the frequency
of mutations. To test this hypothesis, we decided to use the
Ames test [36], and ﬁrst generated two prokaryotic systems
stably overexpressing human frataxin (Figure 2A). As host
cells, we used the Salmonella Typhimurium strain TA1538,
which preferentially detects frameshift mutations [37], and strain
TA104, which preferentially detects base substitutions [38].
Accordingly, the latter strain is highly sensitive to oxidative
damage following exposure to ROS (reactive oxygen species)
[38]. Consistent with our hypothesis, we observed a signiﬁcant
reduction in the number of spontaneous revertants only in TA104
Salmonella overexpressing frataxin, whereas the spontaneous
mutation frequency in TA1538 bacteria remained unaffected
(Figure 2B). Although ISC formation has not been quantiﬁed
directly in these Salmonella strains, these ﬁndings indicate that
ISC-synthesis-promoting frataxin reduces spontaneous mutation
frequency in a Salmonella strain sensitive to oxidative stress.
Benzo[a]pyrene4,5-oxide,ametaboliteofbenzo[a]pyrene,isa
well-characterized mutagen [39] and was tested in both frataxin-
overexpressing strains TA1538-hFX and TA104-hFX, as well
as the corresponding control strains TA1538-Neo and TA104-
Neo. In all strains, a dose-dependent increase in the number
of revertants was detected. However, only in the TA104 strains
did overexpression of frataxin cause a signiﬁcant reduction of
mutation frequency (Figure 2C). The ISC-synthesis-promoting
frataxin therefore speciﬁcally reduces benzo[a]pyrene 4,5-oxide-
induced base substitutions, but not frameshift mutations.
Overexpression of the human frataxin protein reduces DNA base
substitution-mediated mutations in eukaryotes
To possibly extend the above-mentioned effects of frataxin on
prokaryoticDNAmutationstoeukaryotes,weusedthepreviously
establishedHPRTmutagenicitytest.WegeneratedaV79Chinese
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Figure 3 Human frataxin protein diminishes the mutation rate in mammalian hamster ﬁbroblasts
(A) Immunoblotting against haemagglutinin detecting the fully processed (18kDa) and precursor (21kDa) isoforms of stably overexpressed haemagglutinin-tagged human frataxin in V79 cells
(hFX) and mock-transfected control cells (Neo). (B) Oxygen consumption, measured using a Clark-type electrode, as an indicator for frataxin-dependent increase in ISC protein activity. Results are
means+S.D. for three independent experiments. (C) KBrO3-dependent mutagenicity in V79 cells. Results are means+S.D. for eight independent experiments.
Figure 4 Human frataxin protein promotes DNA repair in mammalian hamster ﬁbroblasts
(A) Steady-state (basal) levels of SSBs and Fpg-sensitive modiﬁcations (Fpg) in V79-hFX and control cells. (B) Numbers of SSB and Fpg-sensitive modiﬁcations induced by exposure of the cells
to the photosensitizer Ro 19-8022 plus visible light. (C) Residual numbers of Fpg-sensitive modiﬁcations after DNA damage induction as in (B), followed by a repair incubation of 4h in complete
medium. Results are means+S.D. for seven independent experiments. Signiﬁcant difference between the groups is indicated according to a paired Student’s t test.
hamsterﬁbroblastcelllineoverexpressinghaemagglutinin-tagged
human frataxin protein (V79-hFX) (Figure 3A) and characterized
these cells in comparison with mock-transfected cells (V79-
Neo). As shown previously for frataxin-overexpressing murine
ﬁbroblasts[28]andcoloncancercells[19],weobservedincreased
respiration rates in V79-hFx cells (Figure 3B), indicating that the
protein is functional.
Next, we quantiﬁed mutation rates in these cells. Both over-
expressing and control cells showed low spontaneous mutation
frequencies, i.e. below ﬁve mutations per 10
6 cells (results not
shown). In order to test ROS-induced mutagenicity, we used
KBrO3 to induce mainly Fpg-sensitive oxidative DNA damage
[40]. We tested KBrO3-dependent mutagenicity in the V79 cells
and found diminished mutation frequencies in V79-hFX
cells (P=0.06) (Figure 3C). These ﬁndings suggest that ISC-
synthesis-promoting frataxin may reduce the mutagenicity of
KBrO3 and consequently oxidative damage.
Steady-state levels of DNA damage in frataxin-overexpressing
ﬁbroblasts are decreased, but the extent of DNA damage induction
remains unchanged
Toanalysetheimpactofthefrataxinoverexpressiononthesteady-
state levels of DNA damage, we quantiﬁed both SSB and Fpg-
sensitive modiﬁcations in V79-hFX and control cells by alkaline
elution, as described in the Materials and methods section. As
showninFigure4(A),V79-hFXcellsshowasigniﬁcantreduction
in the basal levels of SSBs. Moreover, we observed a trend
(P=0.096) towards reduced Fpg-sensitive DNA modiﬁcations
(Figure 4A).
Subsequently, we tested whether frataxin-overexpressing cells
differ from control cells with regard to the inducibility of DNA
damage by exposing them to the photosensitizer Ro 19-8022 plus
visible light. In agreement with our previously published results
[41], the treatment generates predominantly oxidative purine
modiﬁcations (8-oxoG) and only few SSBs and other types of
lesion (Figure 4B). Notably, and of relevance for the ﬁndings
summarized within the next paragraph, no differences between
V79-hFX and control cells were detectable for either type of
DNA damage directly after exposure to visible light (Figure 4B).
This indicates that frataxin-overexpressing and control cells do
not differ with respect to their susceptibility to the induction of
oxidative DNA damage.
Frataxin-overexpressing ﬁbroblasts have an increased DNA-repair
capacity
Our initial observation that frataxin-deﬁcient mice develop
liver tumours (Figure 1B) and have increased basal levels
of Fpg-sensitive base modiﬁcations (Figure 1C) gave rise to
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Figure5 FrataxinhasnoinﬂuenceonISC-independentDNA-repaircapacity
Cleavage activity at 8-oxoG sites observed in total protein extracts of V79-hFX and control
cells. (A) Representative gel showing the cleavage of a 34-mer oligonucleotide containing an
8-oxoG residue in a central position by incubation with Fpg (+; positive control), buffer only
(−; negative control), extracts of frataxin-overexpressing cells (hFX) and control cells (Neo).
(B) Results are mean+S.D. cleavage activities (percentage cleavage of the 34-mer) for six
independent experiments.
the assumption that frataxin overexpression and subsequently
increased ISC availability may stimulate the activity of ISC-
dependent DNA repair. To test this hypothesis, we compared the
residual, i.e. unrepaired number of Fpg-sensitive modiﬁcations
in frataxin-overexpressing and control cells 4 h after damage
induction by Ro 19-8022 plus light (see above). The results
indicate that frataxin-overexpression is associated with a
signiﬁcantly lower number of unrepaired Fpg-sensitive oxidative
purine modiﬁcations, i.e. more efﬁcient repair (Figure 4C).
Increased DNA-repair capacity is unrelated to ISC-independent
repair
It has been demonstrated previously that the repair of Fpg-
sensitive oxidative purine modiﬁcations in mammalian cells
depends largely on the activity of the repair glycosylase OGG1,
the eukaryotic functional homologue of the bacterial Fpg protein
[34]. OGG1, however, is not an ISC protein and its activity
is therefore not expected to depend on frataxin. To determine
the activity of OGG1 in V79-hFX and control cells, we
used a cleavage assay, in which the incision capacity of cell
extracts at single 8-oxoG residues in synthetic oligonucleotides
is measured (Figure 5A). Very similar cleavage activity was
observed in total protein extracts of frataxin-overexpressing and
control cells, indicating that the ISC-independent enzyme OGG1
remains unaffected by altered ISC synthesis rates (Figure 5B).
Taken together, these ﬁndings suggest that increased DNA-repair
capacity in frataxin-overexpressing cells (Figure 4C) is unrelated
to ISC-independent repair mechanisms (Figure 5B), but rather
depends on ISC-containing DNA-repair enzymes.
DISCUSSION
The ﬁndings of the present study suggest an important role for a
regulator of ISC synthesis, the frataxin protein, in DNA-damage
repairinbothprokaryotesandmammals.Inparticular,theremoval
of endogenously generated oxidative DNA base damage appears
to strongly depend on frataxin expression.
Owing to environmental factors and normal metabolic
processes within eukaryotic cells, a signiﬁcant amount of DNA
damageoccursonaregularbasis.TwomaintypesofDNAdamage
are oxidized bases (e.g. 8-oxoG) and DNA strand interruptions
due to biochemical by-products such as ROS. DNA-repair
processes are constantly active as they respond to permanently
occurring damages in the DNA structure. When normal repair
processes fail and removal of damaged cells by apoptosis or
senescence does not take place, damage may result in DNA
mutations which subsequently can lead to the formation of
malignantly transformed cells.
Reduced expression of the mitochondrial protein frataxin
causes the neurodegenerative disorder FRDA which has been
linked to various types of cancer on an anecdotal basis [14–17].
The essential role of frataxin as a mitochondrial iron chaperone
for ISC biogenesis is widely accepted, and frataxin deﬁciency
in humans, mice and yeast leads to severe alterations of
mitochondrial and extra-mitochondrial ISC protein activity and
function[10,35,42].Althoughthemalignantdisordersobservedin
FRDApatientshavebeententativelyattributedtotheformationof
non-BDNAstructures(triplexesorstickyDNA)basedonintronic
GAA triplet repeats [43], the effects observed in our model
systems cannot be attributed to such triplet-repeat-dependent
structures: neither the knockout model nor the overexpressing
models carry such GAA repeats. Hence, the current observations
should be considered a direct consequence of the altered frataxin
protein levels rather than altered DNA structure and/or triplet
repeat formation.
In the present study, we have shown that altered expression of
the frataxin protein modulates activity of the DNA-repair system
and is correlated with altered oxidative DNA modiﬁcations as
well as altered mutagenicity, culminating in tumour formation in
mice. In particular, frataxin deﬁciency leads to reduced activity
of ISC proteins and tumour formation in the affected tissue, the
liver,inAlbFxn
−/−-mice[12]whichisassociatedwithanincrease
in Fpg-sensitive DNA modiﬁcations due to frataxin deﬁciency,
as shown in the present study. In contrast, we additionally
show that overexpression of human frataxin in the prokaryote
Salmonella Typhimurium efﬁciently reduces mutagenicity of
the well-characterized compound benzo[a]pyrene 4,5-oxide.
Speciﬁcally, strain TA104, which is known to detect base
substitutionsandtobesensitivetooxidativemutagens[38],shows
both reduced spontaneous as well as benzo[a]pyrene 4,5-oxide-
induced mutation rates [44,45]. In contrast, in the frameshift-
mutation-sensitive strain TA1538 [37], frataxin expression does
not show any detectable effect. These differential effects argue
against a toxicokinetic mechanism; a possible mechanism may
be a frataxin-mediated change in the pattern of translesion
synthesis DNA polymerases, which are important in the ﬁxation
of mutations induced by benzo[a]pyrene 4,5-oxide in Salmonella
[46]. Taken together, these observations are consistent with
the notion that frataxin affects base-substitution-dependent
mutagenesis only, which is also known to occur following
exposure to oxidative stressors. Hence, our ﬁndings are in
accordancewithpreviousstudiesthatsuggestincreasedsensitivity
to oxidative stress in states of frataxin deﬁciency [12,47,48]. It
remains to be elucidated, however, how frataxin protects from
revertant mutations in our prokaryotic model. This effect can
be explained by increased effectiveness of DNA damage repair
due to increased ISC formation, but could also be interpreted
to be caused by ferroxidase and/or iron-detoxiﬁcation activity
of frataxin which then would protect the DNA from oxidative
damage, as suggested previously [6,7].
To extend the effect of frataxin on mutagenicity to eukaryotic
systems, we established V79 Chinese hamster ﬁbroblasts stably
overexpressing human frataxin, and showed increased oxygen
consumption as a prototypical marker for elevated ISC protein
activity within the mitochondria [19,28,35]. Because an exposure
of mammalian cells to KBrO3 generates oxidative DNA
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modiﬁcations, in particular 8-oxoG [49], we used KBrO3 in the
HPRT test and observed a trend towards a reduced mutagenicity
in states of frataxin overexpression (P=0.06). It should be noted,
however, that mutagenicity of KBrO3 in our hands is rather weak,
which is consistent with longstanding ﬁndings [50]. Given the
low basal mutagenic efﬁciency of KBrO3, the comparably weak
protective effect of frataxin in this particular case is not really
surprising.
To elucidate further the mechanistic basis for ISC-mediated
DNA damage protection, we used the highly sensitive alkaline
elution technique [30]. We observed reduced steady-state levels
of SSBs and Fpg-sensitive modiﬁcations, suggesting that frataxin
either protects against oxidative DNA damage or promotes DNA
repair. However, it should be emphasized that these ﬁndings need
to be interpreted with caution since (i) SSB levels were near the
detection limit of the technique, and (ii) ﬁndings on Fpg-sensitive
modiﬁcations were not statistically signiﬁcant.
To test whether frataxin overexpression directly protects
from induction of DNA damage, or whether frataxin rather
promotes DNA repair, we induced oxidative DNA damage by
photosensitization. When quantifying the degree of damage
immediately after irradiation, no difference with regard to DNA-
damage frequency was observed. Thereby we aimed to exclude
the possibility that frataxin affects the primary induction of
damageinparticularwithregardtoirondetoxiﬁcation.Incontrast,
4 h after induction of damage to a similar degree in frataxin-
overexpressing and control cells, a signiﬁcant reduction in the
extent of DNA damage was observed in frataxin-overexpressing
V79 cells when compared with control cells, thus indicating that
DNA-repair capacity is, in fact, modulated by frataxin (Figure 4).
Consistent with the ﬁndings in frataxin-overexpressing cells, we
could inversely show that the steady-state level of Fpg-sensitive
DNA modiﬁcations in hepatocytes isolated from young frataxin-
deﬁcient AlbFxn
−/− mice was increased, notably in the absence
of any external ROS-inducing or mutagenic stimulus (Figure 1).
Frataxin is a mitochondrial protein that is crucial for the
mitochondrial biosynthesis of ISCs. However, DNA repair and
speciﬁcally BER is mediated by several enzymes which partly
depend on ISCs, whereas others do not require ISCs, the latter
including OGG1. Accordingly, we here observed that OGG1
is not affected by expression levels of frataxin and hence ISC
availability. Although experimentally highly challenging, future
experimentswillideallyhavetoshowwhichISC-dependentrepair
enzymes are affected by frataxin expression. However, given (i)
the frataxin-mediated induction of repair capacity, as well as (ii)
the fact that ISC-independent OGG1 activity does not contribute
to this phenotype, it strongly suggests that frataxin exerts its
effects via modulation of ISC-dependent DNA-repair enzymes.
Moreover, the ﬁndings described in the present study indicate
that a human mitochondrial protein can be functional not
only in mammalian cells, but also in prokaryotes, which lack
mitochondria. This observation is consistent with the fact that
frataxinisevolutionarilyconservedthroughoutmostspecies[25].
Taken together, the present study suggests that frataxin
and apparently ISC availability modulate DNA-repair capacity
in evolutionary distinct phyla and protect mammals from
spontaneous liver tumour formation.
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